HeartBeam, Inc (BEAT) Misses Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall St set for lower open as Alphabet results reignite AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
HeartBeam Reports Third Quarter 2022 Financial Results
November 10, 2022 4:01 PM ESTÂ HeartBeam AIMI Platform Technology for use in Diagnosing Heart Attacks Submitted to FDA for Clearance
Company on Track for Initial FDA Submission of HeartBeam AIMIGo, the Telehealth Solution, in Q4 2022
AIMIGo Technology Receives Two Additional Patents
Company Plans to Broaden Product Portfolio Pipeline with Smartwatch Connectivity
Management to Host Webcast and Conference Call Today At 4:30 p.m. ET
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology... More



